N-Benzyl-6-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine CAS 915373-27-2
| CAS No. | 915373-27-2 |
| Molecular Formula | C18H15N5 |
| Molecular Weight | 301.35 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The molecular framework of N-Benzyl-6-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine (C18H15N5) is characterized by a nitrogen-containing heterocyclic scaffold, a nitrile group. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
N-Benzyl-6-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine (CAS 915373-27-2) is a high-purity analytical reference standard with the molecular formula C18H15N5 and a molecular weight of 301.35 g/mol.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
As a certified reference material (CRM), N-Benzyl-6-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C18H15N5 |
| Molecular Weight | 301.35 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 14.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Nitrogen Atoms | 5 |
Recommended Standards
- GSK-3 Inhibitor XIII (CAS 404828-08-6)
- O8-tert-butyl O3-ethyl 3-fluoro-8-azabicyclo[3.2.1]octane-3,8-dicarboxylate (CAS 2113560-43-1)
- 9-Benzyl-2-phenyl-9H-purin-6-amine (CAS 640274-34-6)
- Phenyl-(9-p-tolyl-9H-purin-6-yl)-amine (CAS 944833-33-4)
- Pyrimidine, 2-chloro-4-(3,4-dimethoxyphenyl)-5-fluoro- (CAS 1494526-17-8)
- 3-(1,3-Dimethyl-1H-pyrazol-5-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine (CAS 1174873-10-9)
- 4-(4-Amino-2-chlorophenoxy)benzonitrile (CAS 66658-86-4)
- 5-Bromo-4-ethoxy-3-methylbenzofuran-2-carboxylic acid (CAS 1403566-71-1)
- Selenomorpholine (CAS 200629-55-6)
- 4-(5,5-Dimethyl-1,3-dioxan-2-yl)-3-nitrovalerophenone (CAS 898786-33-9)
- Fmoc-Gly-Arg（Pbf）-OH (CAS 1048377-78-1)
- 2-((4-Ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-ethylphenyl)acetamide (CAS 557069-45-1)
- 1-(2-((4-(Pyrimidin-2-yl)piperazin-1-yl)sulfonyl)ethyl)-3-(thiophen-2-yl)urea (CAS 1207005-68-2)
- Endo-Ala35-Tirzepatide (CAS CATO-CPTD788687)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com